Nureca P/E Ratio
Nureca (NURECA) P/E ratio is not applicable — EPS (TTM) ₹2.11, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹2.11
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -6.45 | -6 | Loss |
| Sept 2025 | 3.63 | 4 | Profit |
| Mar 2025 | 2.47 | 3 | Profit |
| Jun 2025 | 0.81 | 1 | Profit |
| Dec 2025 | 3.91 | 4 | Profit |
| Sept 2024 | -0.48 | -1 | Loss |
| Mar 2024 | -4.15 | -4 | Loss |
| Jun 2024 | 1.66 | 2 | Profit |
Healthcare Peers with Valid P/E Ratios — NURECA Comparison
Healthcare sector average P/E 54.99, median 31.04 — NURECA excluded (negative EPS).
Sector Average PE
54.99
Sector Median PE
31.04
Lowest PE
2.86
Profitable Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Nureca share price chart.
- Read NURECA dividend payout details for the complete payout history and dividend yield track record.
- See NURECA price to book ratio to compare market price against book value per share.